Title |
Classification of anti hepatitis peptides using Support Vector Machine with hybrid Ant Colony Optimization
|
Authors |
Gunjan Mishra1#, Vivek Ananth1#, Kalpesh Shelke2, Deepak Sehgal1 & Jayaraman Valadi1*
|
Affiliation |
1Shiv Nadar University, Gautam Budha Nagar, Utter Pradesh 201314, India
2Centre for Modeling and Simulation, Pune University, Pune 4110001, India
|
|
valadi@gmail.com; *Corresponding author |
Article Type |
Prediction Model |
Date |
Received January 04, 2016; Accepted January 06, 2016; Published January 31, 2016
|
Abstract |
Hepatitis is an emerging global threat to public health due to associated mortality, morbidity, cancer and HIV co-infection. Available diagnostics and therapeutics are inadequate to intercept the course and transmission of the disease. Antimicrobial peptides (AMP) are widely studied and broad-spectrum host defense peptides are investigated as a targeted anti-viral. Therefore, it is of interest to describe the supervised identification of anti-hepatitis peptides. We used a hybrid Support Vector Machine (SVM) with Ant Colony Optimization (ACO) algorithm for simultaneous classification and domain feature selection. The described model shows a 10 fold cross-validation accuracy of 94%. This is a reliable and a useful tool for the prediction and identification of hepatitis specific drug activity.
|
Keywords |
Antiviral peptides, Support vector machine, Hepatitis, Ant colony optimization, Feature selection
|
Abbreviations |
AMP = Antimicrobial peptides, SVM = Support Vector Machines, HIV = Human Immunodeficiency Virus, AC O = Ant Colony Optimization, AHP = Anti Hepatitis Peptides
|
Citation |
Mishra et al. Bioinformation
12(1): 12-14 (2016) |
Edited by |
P Kangueane
|
ISSN |
0973-2063
|
Publisher |
|
License | This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License. |